Emotional and Physical Health Status of Adults
Sponsor
Pamukkale University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05206903
Collaborator
(none)
250
3.9
Study Details
Study Description
Brief Summary
To investigate the comparison of differences between emotional and physical health status of adults in COVID-19 isolation period and controlled normalization period.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
250 participants
Observational Model:
Other
Time Perspective:
Cross-Sectional
Official Title:
Emotional and Physical Health Status of Adults in Pandemia
Anticipated Study Start Date
:
Feb 10, 2022
Anticipated Primary Completion Date
:
Apr 10, 2022
Anticipated Study Completion Date
:
Jun 10, 2022
Outcome Measures
Primary Outcome Measures
- Pandemic Awareness Scale [1 minute]
To investigate the public pandemia awareness
- Chalder Fatigue Scale [2 minutes]
A self-report scale which is used to assess perceived fatique.
- Pittsburgh Sleep Quality Index [3 minutes]
A self-report scale
- EQ-5D Health-Related Quality of Life Questionnaire [1 minute]
This scale consists of 5 dimensions as mobility, self-care, usual activities, pain/discomfort and anxiety/depression.
- Physical Activity Score [1 minute]
The level of physical activity
Eligibility Criteria
Criteria
Ages Eligible for Study:
20 Years
to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
-
To speak Turkish
-
Living in Turkey in pandemic process.
-
Between the ages of 20-60 years.
-
No communication problems.
-
Being volunteer to participate in study.
Exclusion Criteria:
-
Having communication problems.
-
Not completion the assessments.
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Pamukkale University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Ayşe Ünal,
PT., PhD.,
Pamukkale University
ClinicalTrials.gov Identifier:
NCT05206903
Other Study ID Numbers:
- 21.01.2022/pandemia.awareness
First Posted:
Jan 25, 2022
Last Update Posted:
Jan 25, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ayşe Ünal,
PT., PhD.,
Pamukkale University
Additional relevant MeSH terms: